← All organizations
Highest phase reached
Phase 1
First clinical trial
Nov 6, 2020Last known activity
Nov 6, 2020
Defunct as of Dec 31, 2025
Timeline
2010s
- Jun 1, 2015
Immunomolecular Therapeutics, Inc.— Founded
2020s
- Dec 31, 2025
Immunomolecular Therapeutics, Inc.— Defunct
Drugs by trial phase (1 distinct, 1 trials)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (1)
- NCT04625595Lead sponsorPhase 1Nov 6, 2020
Details
- Founded
- Aurora, CO, US Jun 1, 2015
- Last known activity
- Nov 6, 2020